- Home
- PCTY vs PCVX Comparison
PCTY vs PCVX Comparison
Compare PCTY & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PCTY | PCVX |
|---|---|---|
| Founded | 1997 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 7.0B |
| IPO Year | 2014 | 2020 |
Fundamental Metrics
Financial Performance| Metric | PCTY | PCVX |
|---|---|---|
| Price | $112.52 | $47.21 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 17 | 4 |
| Target Price | ★ $176.59 | $88.25 |
| AVG Volume (30 Days) | 745.4K | ★ 1.5M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 10.74 | N/A |
| EPS | ★ 3.81 | N/A |
| Revenue | ★ $1,595,221,000.00 | N/A |
| Revenue This Year | $11.52 | N/A |
| Revenue Next Year | $7.98 | N/A |
| P/E Ratio | $29.35 | ★ N/A |
| Revenue Growth | ★ 13.74 | N/A |
| 52 Week Low | $92.99 | $29.10 |
| 52 Week High | $197.92 | $65.00 |
Technical Indicators
Market Signals| Indicator | PCTY | PCVX |
|---|---|---|
| Relative Strength Index (RSI) | 57.69 | 28.17 |
| Support Level | $101.50 | $42.30 |
| Resistance Level | $116.99 | $49.46 |
| Average True Range (ATR) | 5.10 | 2.64 |
| MACD | 0.68 | -0.80 |
| Stochastic Oscillator | 64.43 | 5.80 |
Price Performance
Historical ComparisonAbout PCTY Paylocity Holding Corporation
Founded in 1997, Paylocity is a cloud-based human capital management and payroll platform servicing midmarket customers. The company's average client size is around 150 employees. Its products help with recruiting and onboarding, payroll, time and labor, human resources, benefits, learning, and performance and compensation workflows. In fiscal 2025, the company generated over $1.5 billion in revenue across more than 41,000 customers.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.